Arthur Fratamico

Arthur Fratamico

Direktor/Vorstandsmitglied bei SUN BIOPHARMA INC
61 Jahre
Health Technology
Consumer Services

Profil

Arthur J.
Fratamico
is currently an Independent Director at Panbela Therapeutics, Inc., a position held since 2019.
Formerly, Mr. Fratamico was President & Chief Executive Officer at Radiant Biotherapeutics, Inc., Vice President-Business Development & Licensing at MGI PHARMA, Inc., Chief Business Officer at Flexion Therapeutics, Inc. from 2012 to 2014, Chief Business Officer at Vitae Pharmaceuticals LLC from 2014 to 2016, Vice President-Business & Strategic Development at Gemin X Pharmaceuticals US, Inc. from 2009 to 2010, Principal at Hoechst Marion Roussel, Inc., Chief Business Officer at Trevena, Inc., and Chief Business Officer at Galera Therapeutics, Inc. Education includes an MBA from Drexel University and undergraduate studies at Philadelphia College of Pharmacy.

Aktive Positionen von Arthur Fratamico

UnternehmenPositionBeginn
SUN BIOPHARMA INC Direktor/Vorstandsmitglied 16.12.2019

Ehemalige bekannte Positionen von Arthur Fratamico

UnternehmenPositionEnde
VITAE PHARMACEUTICALS INC Corporate Officer/Principal 25.12.2016
FLEXION THERAPEUTICS, INC. Corporate Officer/Principal 01.01.2014
Vorstandsvorsitzender -
GALERA THERAPEUTICS, INC. Corporate Officer/Principal -
TREVENA, INC. Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Arthur Fratamico im Detail an

Ausbildung von Arthur Fratamico

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

29

Beziehungen ersten Grades

11

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen11

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Arthur Fratamico